Selected research
Market Structure
Global Levosulpiride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Levosulpiride market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Suzhou Chenghe Pharmaceutical & Chemical, Harbin Gloria Pharmaceuticals, Vasoya Industries, New Donghai Pharmaceutical and Bona Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Levosulpiride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Levosulpiride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Levosulpiride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Levosulpiride market size, projected growth trends, production technologies, key applications, and end-use industries.
Levosulpiride Segment by Company
Sun Pharmaceutical Industries
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Vasoya Industries
New Donghai Pharmaceutical
Bona Chemical
Levosulpiride Segment by Type
Above 98%
Below 98%
Levosulpiride Segment by Application
Tablet
Capsule
Other
Levosulpiride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levosulpiride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levosulpiride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levosulpiride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Levosulpiride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Sun Pharmaceutical Industries
- Suzhou Chenghe Pharmaceutical & Chemical
- Harbin Gloria Pharmaceuticals
- Vasoya Industries
- New Donghai Pharmaceutical
- Bona Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Levosulpiride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Levosulpiride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Levosulpiride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Levosulpiride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Levosulpiride Market Dynamics
- 2.1 Levosulpiride Industry Trends
- 2.2 Levosulpiride Industry Drivers
- 2.3 Levosulpiride Industry Opportunities and Challenges
- 2.4 Levosulpiride Industry Restraints
3 Levosulpiride Market by Manufacturers
- 3.1 Global Levosulpiride Revenue by Manufacturers (2021-2026)
- 3.2 Global Levosulpiride Sales by Manufacturers (2021-2026)
- 3.3 Global Levosulpiride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Levosulpiride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Levosulpiride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Levosulpiride Manufacturers, Product Type & Application
- 3.7 Global Levosulpiride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Levosulpiride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Levosulpiride Players Market Share by Revenue in 2025
- 3.8.3 2025 Levosulpiride Tier 1, Tier 2, and Tier 3
4 Levosulpiride Market by Type
- 4.1 Levosulpiride Type Introduction
- 4.1.1 Above 98%
- 4.1.2 Below 98%
- 4.2 Global Levosulpiride Sales by Type
- 4.2.1 Global Levosulpiride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Levosulpiride Sales by Type (2021-2032)
- 4.2.3 Global Levosulpiride Sales Market Share by Type (2021-2032)
- 4.3 Global Levosulpiride Revenue by Type
- 4.3.1 Global Levosulpiride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Levosulpiride Revenue by Type (2021-2032)
- 4.3.3 Global Levosulpiride Revenue Market Share by Type (2021-2032)
5 Levosulpiride Market by Application
- 5.1 Levosulpiride Application Introduction
- 5.1.1 Tablet
- 5.1.2 Capsule
- 5.1.3 Other
- 5.2 Global Levosulpiride Sales by Application
- 5.2.1 Global Levosulpiride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Levosulpiride Sales by Application (2021-2032)
- 5.2.3 Global Levosulpiride Sales Market Share by Application (2021-2032)
- 5.3 Global Levosulpiride Revenue by Application
- 5.3.1 Global Levosulpiride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Levosulpiride Revenue by Application (2021-2032)
- 5.3.3 Global Levosulpiride Revenue Market Share by Application (2021-2032)
6 Global Levosulpiride Sales by Region
- 6.1 Global Levosulpiride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Levosulpiride Sales by Region (2021-2032)
- 6.2.1 Global Levosulpiride Sales by Region (2021-2026)
- 6.2.2 Global Levosulpiride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Levosulpiride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Levosulpiride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Levosulpiride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Levosulpiride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Levosulpiride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Levosulpiride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Levosulpiride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Levosulpiride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Levosulpiride Revenue by Region
- 7.1 Global Levosulpiride Revenue by Region
- 7.1.1 Global Levosulpiride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Levosulpiride Revenue by Region (2021-2026)
- 7.1.3 Global Levosulpiride Revenue by Region (2027-2032)
- 7.1.4 Global Levosulpiride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Levosulpiride Revenue (2021-2032)
- 7.2.2 North America Levosulpiride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Levosulpiride Revenue (2021-2032)
- 7.3.2 Europe Levosulpiride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Levosulpiride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Levosulpiride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Levosulpiride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Levosulpiride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical Industries
- 8.1.1 Sun Pharmaceutical Industries Company Information
- 8.1.2 Sun Pharmaceutical Industries Business Overview
- 8.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
- 8.1.5 Sun Pharmaceutical Industries Recent Developments
- 8.2 Suzhou Chenghe Pharmaceutical & Chemical
- 8.2.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
- 8.2.2 Suzhou Chenghe Pharmaceutical & Chemical Business Overview
- 8.2.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
- 8.2.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments
- 8.3 Harbin Gloria Pharmaceuticals
- 8.3.1 Harbin Gloria Pharmaceuticals Company Information
- 8.3.2 Harbin Gloria Pharmaceuticals Business Overview
- 8.3.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
- 8.3.5 Harbin Gloria Pharmaceuticals Recent Developments
- 8.4 Vasoya Industries
- 8.4.1 Vasoya Industries Company Information
- 8.4.2 Vasoya Industries Business Overview
- 8.4.3 Vasoya Industries Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Vasoya Industries Levosulpiride Product Portfolio
- 8.4.5 Vasoya Industries Recent Developments
- 8.5 New Donghai Pharmaceutical
- 8.5.1 New Donghai Pharmaceutical Company Information
- 8.5.2 New Donghai Pharmaceutical Business Overview
- 8.5.3 New Donghai Pharmaceutical Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
- 8.5.5 New Donghai Pharmaceutical Recent Developments
- 8.6 Bona Chemical
- 8.6.1 Bona Chemical Company Information
- 8.6.2 Bona Chemical Business Overview
- 8.6.3 Bona Chemical Levosulpiride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Bona Chemical Levosulpiride Product Portfolio
- 8.6.5 Bona Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Levosulpiride Value Chain Analysis
- 9.1.1 Levosulpiride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Levosulpiride Production Mode & Process
- 9.2 Levosulpiride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Levosulpiride Distributors
- 9.2.3 Levosulpiride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst